ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,529, issued on Feb. 17, was assigned to FORMYCON AG (Martinsried/Planegg, Germany).
"Liquid formulation of a VEGF antagonist" was invented by Rainer Sigl (Landsberg am Lech, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to liquid pharmaceutical compositions of a VEGF antagonist for intravitreal administration comprising a histidine buffer, an inorganic salt, a carbohydrate and a polysorbate."
The patent was filed on Feb. 23, 2023, under Application No. 18/173,549.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&...